Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy

Recruiting now · Not applicable

Conditions studied: Gastric Cancer, Immunonutrition, Gastrostomy

In brief

Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcinoma patients undergoing gastrectomy. The secondary endpoints, including the physical activity, weight loss, and nutritional profiles, will be evaluated among these patients.

Key facts

Study ID

NCT06027242

Run by

National Taiwan University Hospital

People needed

120

Starts

2023-02-21

Expected to finish

2026-08-30

Last updated by the study team

2025-12-23

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult gastric cancer receiving gastrectomy

You may not qualify if…

• Hepatic insufficiency
• Renal insufficiency
• can not tolerate oral or enteral feeding 7 days after gastrectomy
• can not receive computed tomograph
• can not waer the wearable devices

Where it is running

• National Taiwan University Hospital — Taipei, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.